Transfusion of Platelets Containing ABO-Incompatible Plasma: A Survey of 3156 North American Laboratories

Abstract

A majority of laboratories have a policy, but most do not include a method to limit the risk of hemolysis if platelets containing ABO-incompatible plasma must be transfused. When such platelets are used, there does not appear to be consensus on a specific method to minimize the transfusion of anti-A or anti-B.